Indonesian Version of Oxford Cognitive Screen-Plus Test in Stroke Patient
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitas Padjadjaran
About this trial
The incidence of stroke increases every year throughout the world. Neuropsychological assessment is the best way to identify post-stroke cognitive dysfunction. The importance of cognitive function in the post stroke rehabilitation program process requires a tool that can detect cognitive disorders more specifically and more sensitively. The investigator aim in this study was to develop Indonesian version of the OCS - Plus among stroke patient in Indonesia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female18 years of age or older
Subacute and chronic stroke patients
Able to understand instructions
Able to read
Disqualifiers
Have uncorrected severe visual and hearing impairments
Have cognitive rehabilitation before research
Inability to maintain concentration for approximately 30 minutes
Trial population
The target population consists of stroke patients in West Java. The accessible population includes stroke patients undergoing treatment at the medical rehabilitation clinic and neurology clinic at RSUP Dr. Hasan Sadikin Bandung
Trial design
Design model
Other
Time perspective
Cross-sectional
Treatments tested in this trial
OCS Plus Assessment
DeviceSubject is going to carry out Indonesian OCS Plus assessment in accordance with the procedure given by the application.
Treatment groups
75 Participants
are divided into 1 treatment groupGroup A: Validity/Reliability Group1 intervention
Trial outcomes
Primary outcomes
1
Validity and Reliability of Indonesian OCS Plus
Task-specific OCS-Plus convergent and divergent validity was examined against task-matched validated MoCA tests in a pre-registered Spearman's Rho correlation analyses. Investigator's aimed for correlations \>0.30 to demarcate convergence. The reliability coefficient calculation technique used here is to use the Alpha Reliability Coefficient.
Time frame
T0 - Baseline assessment (Day 1) -. Informed consent and Demographic -. MoCA-Ina -. Indonesian OCS-Plus T1 - Retest (48 hours after T0) -.Indonesian OCS-Plus repeated under standardized conditions -.No cognitive rehabilitation intervention between T0-T1Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universitas Padjadjaran
Lead sponsor
University of Oxford
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: